Skip to main content

Table 2 Comparing input and output variables in three sets

From: Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers

Variables

Patients in the training set, n = 226

Patients in the validation set, n = 113

Patients in the testing set, n = 116

χ2(p)

Age(years)

30(16-62)

35(16-75)

32(16-74)

1.741(0.419)

WBC(109/L)

5.4(1.3-18.1)

5.5(2.5-16.8)

5.4(3.0-11)

0.231(0.891)

RBC(1012/L)

4.7(2.6-4.0)

4.7(3.6-5.7)

4.6(3.7-5.6)

0.310(0.856)

Platelet(109/L)

165(53-246)

170(13-350)

185(46-345)

4.965(0.083)

ALT(U/L)

87(16-471)

80(11-536)

72(6-507)

2.475(0.290)

AST(U/L)

48(11-413)

42.5(15-375)

39(11-361)

1.264(0.531)

GGT(U/L)

29(6-421)

33(6-288)

34(10-473)

3.247(0.197)

ChE(U/L)

8402(50-20427)

7674(145-11374)

7258(360-12648)

3.051(0.217)

Alb(g/L)

44.8(10.9-47.0)

44.2(11.8-50.7)

44.1(31.3-52.6)

0.412(0.814)

TBIL(μmol/L)

14.1(3.6-216)

15.3(3-196)

13.2(3- 134)

3.650(0.161)

Fibrosis

F(0-1)/F(2-4)

166/60

83/30

80/36

0.657(0.720)